News & Perspective

Aug 13, 2009

Aug 13, 2009

Experts air practical PPE considerations to IOM

(CIDRAP News) – On the second and final day of an Institute of Medicine (IOM) task force meeting on how to protect healthcare workers from the novel H1N1 virus, experts focused on issues surrounding the effectiveness and practical use of masks and respirators in work settings.

The IOM task force's goal is to make recommendations about how to protect healthcare workers during the H1N1 pandemic.

Sep 03, 2009

Sep 03, 2009

Feds engage media on pandemic vaccine communication

(CIDRAP News) – In advance of the expected pandemic H1N1 vaccination campaign this fall, the US Department of Health and Human Services (HHS) yesterday invited the media to join federal officials in a tabletop exercise to prepare for some possible communications challenges.

Sep 11, 2009

Sep 11, 2009

Roche boosts Tamiflu supply, addresses resistance

(CIDRAP News) – Officials from Roche today said the company is producing Tamiflu (oseltamivir) at near-capacity levels and is collaborating on dozens of research studies, focusing on groups such as pregnant women who are at higher risk of complications from pandemic H1N1 flu.

Sep 18, 2009

Sep 18, 2009

CDC says 3.4 million doses of H1N1 vaccine to ship in early October

(CIDRAP News) – The first wave of H1N1 vaccine will probably consist of 3.4 million doses of MedImmune's nasal-spray product and is likely to reach providers the first week in October, federal health officials said today.

Nov 24, 2009

Nov 24, 2009

Novartis unveils US cell-based flu vaccine plant

(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.

Dec 15, 2009

Dec 15, 2009

Sanofi recalls some pediatric pandemic vaccine doses

(CIDRAP News) – Sanofi has recalled four lots of its prefilled syringe pandemic vaccine for children ages 6 months through 35 months after its post-distribution monitoring found that antigen content dropped slightly below required levels, a problem that federal officials say isn't linked to any safety concerns.

Jan 04, 2010

Jan 04, 2010

Three H1N1 vaccine studies confirm safety, weigh dosing

(CIDRAP News) – Large trials in three countries—the United States, Hungary, and China—recently confirmed the safety and efficacy of H1N1 vaccines, yielding new insights on how to best use vaccines in a pandemic setting.

Feb 03, 2010

Feb 03, 2010

CDC alert details shorter expiration for Sanofi pandemic vaccine doses

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) yesterday notified healthcare providers that 50 lots of Sanofi Pasteur's pandemic H1N1 vaccine in prefilled syringes have a shorter shelf life than shown on the label.

Apr 21, 2010

Apr 21, 2010

WHO advisors stay course on H1N1 vaccine, Rotarix

(CIDRAP News) – The World Health Organization's (WHO's) vaccine advisory group recently agreed to keep in place its guidance on pandemic H1N1 vaccines and discussed contamination issues related to the Rotarix rotovirus vaccine.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»